Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Angptl4 protein, mouse × Clear all

Phase

Status

Completed 6 Recruiting 4 Withdrawn 1 Unknown 1 Terminated 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 1 Fasting 1 Breast Neoplasms 1

Interventions

Cisplatin 466 Radiotherapy 338 Cyclophosphamide 324 Carboplatin 323 Capecitabine 303 Paclitaxel 302 Oxaliplatin 294 Docetaxel 280 Gemcitabine 277 Fluorouracil 255 apatinib 231 Drug Therapy 230 Bevacizumab 214 camrelizumab 192 Etoposide 178 Irinotecan 165 Doxorubicin 159 Leucovorin 137 Dexamethasone 137 Cytarabine 131 Blood Specimen Collection 131 pembrolizumab 124 Neoadjuvant Therapy 124 sintilimab 120 Pemetrexed 119 anlotinib 118 toripalimab 115 Rituximab 113 S 1 (combination) 112 Surgical Procedures, Operative 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown

BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡